Enviva Partners (NYSE:EVA) reported quarterly sales of $325.70 million which missed the analyst consensus estimate of $352.16 million by 7.51 percent. This is a 37.20 percent increase over sales of $237.40 million the same period last year.
Price Over Earnings Overview: AstraZeneca
In the current market session, AstraZeneca Inc. (NASDAQ:AZN) stock price is at $74.38, after a 0.28% drop. However,…